TY - JOUR
T1 - Efficient Innate Immune Killing of Cancer Cells Triggered by Cell-Surface Anchoring of Multivalent Antibody-Recruiting Polymers
AU - Uvyn, Annemiek
AU - de Coen, Ruben
AU - Gruijs, Mandy
AU - Tuk, Cees W.
AU - de Vrieze, Jana
AU - van Egmond, Marjolein
AU - de Geest, Bruno G.
PY - 2019/9/9
Y1 - 2019/9/9
N2 - Binding of monoclonal antibodies (mAbs) onto a cell surface triggers antibody-mediated effector killing by innate immune cells through complement activation. As an alternative to mAbs, synthetic systems that can recruit endogenous antibodies from the blood stream to a cancer cell surface could be of great relevance. Herein, we explore antibody-recruiting polymers (ARPs) as a novel class of immunotherapy. ARPs consist of a cell-binding motif linked to a polymer that contains multiple small molecule antibody-binding motifs along its backbone. As a proof of concept, we employ a lipid anchor that inserts into the phospholipid cell membrane and make use of a polymeric activated ester scaffold onto which we substitute dinitrophenol as an antibody-binding motif. We demonstrate that ARPs allow for high avidity antibody binding and drive antibody recruitment to treated cells for several days. Furthermore, we show that ARP-treated cancer cells are prone to antibody-mediated killing through phagocytosis by macrophages.
AB - Binding of monoclonal antibodies (mAbs) onto a cell surface triggers antibody-mediated effector killing by innate immune cells through complement activation. As an alternative to mAbs, synthetic systems that can recruit endogenous antibodies from the blood stream to a cancer cell surface could be of great relevance. Herein, we explore antibody-recruiting polymers (ARPs) as a novel class of immunotherapy. ARPs consist of a cell-binding motif linked to a polymer that contains multiple small molecule antibody-binding motifs along its backbone. As a proof of concept, we employ a lipid anchor that inserts into the phospholipid cell membrane and make use of a polymeric activated ester scaffold onto which we substitute dinitrophenol as an antibody-binding motif. We demonstrate that ARPs allow for high avidity antibody binding and drive antibody recruitment to treated cells for several days. Furthermore, we show that ARP-treated cancer cells are prone to antibody-mediated killing through phagocytosis by macrophages.
UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85069811525&origin=inward
UR - https://www.ncbi.nlm.nih.gov/pubmed/31206941
U2 - 10.1002/anie.201905093
DO - 10.1002/anie.201905093
M3 - Article
C2 - 31206941
VL - 58
SP - 12988
EP - 12993
JO - Angewandte Chemie International Edition in English
JF - Angewandte Chemie International Edition in English
SN - 1433-7851
IS - 37
ER -